Research output per year
Research output per year
Search results
-
2014
Dose calculations for [(131)i] meta-iodobenzylguanidine-induced bystander effects
Gow, M. D., Seymour, C. B., Mairs, R. J., Boyd, M., Prestiwch, W. V. & Mothersill, C. E., Jan 2014, In: Dose-response : a publication of International Hormesis Society. 12, 1, p. 1-23 23 p.Research output: Contribution to journal › Article › peer-review
5 Link opens in a new tab Citations (Scopus) -
2013
The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells
Rae, C., Tesson, M., Babich, J. W., Boyd, M., Sorensen, A. & Mairs, R. J., 1 Jun 2013, In: The Journal of Nuclear Medicine. 54, 6, p. 953-960 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile70 Link opens in a new tab Citations (Scopus)132 Downloads (Pure) -
Gamma irradiation and targeted radionuclides enhance the expression of the noradrenaline transporter transgene controlled by the radio-inducible p21WAF1/CIP1 promoter
McCluskey, A. G., Mairs, R. J., Sorensen, A., Robson, T., McCarthy, H. O., Pimlott, S. L., Babich, J. W., Champion, S. & Boyd, M., Mar 2013, In: Radiation Research . 179, 3, p. 282-292 11 p.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Citations (Scopus) -
The role of copper in disulfiram-induced toxicity and radiosensitisation of cancer cells.
Rae, C., Tesson, M., Babich, J. W., Boyd, M., Sorensen, A. & Mairs, R. J., 2013, (Accepted/In press) In: The Journal of Nuclear Medicine. 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile108 Downloads (Pure) -
2012
In vivo evaluation of a cancer therapy strategy combining HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy
Sorensen, A., Mairs, R. J., Braidwood, L., Joyce, C., Conner, J., Pimlott, S. L., Brown, M. & Boyd, M., 1 Apr 2012, In: The Journal of Nuclear Medicine. 53, 4, p. 647-654 8 p.Research output: Contribution to journal › Article › peer-review
17 Link opens in a new tab Citations (Scopus) -
2011
Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumors
Mairs, R. J. & Boyd, M., 2011, In: Seminars in Nuclear Medicine. 41, 5, p. 334-44 11 p.Research output: Contribution to journal › Article › peer-review
15 Link opens in a new tab Citations (Scopus) -
2010
Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma
Joyal, J. L., Barrett, J. A., Marquis, J. C., Chen, J., Hillier, S. M., Maresca, K. P., Boyd, M., Gage, K., Nimmagadda, S., Kronauge, J. F., Friebe, M., Dinkelborg, L., Stubbs, J. B., Stabin, M. G., Mairs, R., Pomper, M. G. & Babich, J. W., May 2010, In: Cancer Research. 70, 10, p. 4045-4053 9 p.Research output: Contribution to journal › Article › peer-review
51 Link opens in a new tab Citations (Scopus) -
2008
Experimental targeted therapy using [211At]meta-astatobenzylguanidine and transfection of the noradrenaline transporter gene
Boyd, M., McCluskey, A. G., Sorensen, A. & Mairs, R. J., 1 Jun 2008, In: Current Radiopharmaceuticals. 1, 3, p. 197-202 6 p.Research output: Contribution to journal › Article › peer-review